Implementing substance abuse group therapy clinical trials in real-world settings: challenges and strategies for participant recruitment and therapist training in the Women's Recovery Group Study
- PMID: 24724875
- PMCID: PMC3986814
- DOI: 10.1111/j.1521-0391.2014.12099.x
Implementing substance abuse group therapy clinical trials in real-world settings: challenges and strategies for participant recruitment and therapist training in the Women's Recovery Group Study
Abstract
Background and objectives: Open-enrollment group therapy research is challenged by the participant recruitment necessary to ensure continuous group enrollment. We present successful strategies to overcome the following barriers during the Women's Recovery Group (WRG) two-site clinical trial (N = 158): maintenance of sample size and balanced gender randomization during continuous enrollment, maintenance of group attendance, and training and retention of therapists over the 24-month continuous group enrollment.
Methods: To increase recruitment, we targeted referral sources yielding the highest enrollment conversion at each site. Group sessions were consistently held regardless of group size. Therapists were trained in two teams allowing for coverage and uninterrupted treatment over 24 months.
Results: At both sites recruitment and enrollment increased with each successive quarter. Sample size and end date targets were met without disruptions in treatment. Group therapists reported high satisfaction with their training and treatment experiences.
Discussion and conclusions: These strategies supported targeted enrollment and study duration, stability of open-enrollment group therapy frame, and therapist retention and satisfaction.
Scientific significance: Applying these strategies can aid in providing evidence-based group therapy in both clinical and research settings.
© American Academy of Addiction Psychiatry.
Conflict of interest statement
The authors report no conflicts of interest. Dr. Bailey discloses that she is the recipient of grants from the National Institute on Drug Abuse, Alkermes, Inc. BioDelivery Sciences International, Inc. and Titan Pharmaceuticals, Inc. Dr. Bailey has also received travel funds from Titan Pharmaceuticals. The authors alone are responsible for the content and writing of this paper.
Figures
References
-
- Wells KB. Treatment research at the crossroads: The scientific interface of clinical trials and effectiveness research. Am J Psychiatry. 1999;156(1):5–10. - PubMed
-
- Lamb S, Greenlick M, McCarty D, editors. Bridging the Gap Between Practice and Research: Forging Partnerships with Community-Based Drug and Alcohol Treatment. Washington, D.C: National Academy Press; 1998. - PubMed
-
- Weiss RD, Jaffee WB, de Menil VP, Cogley CB. Group therapy for substance use disorders: What do we know? Harv Rev Psychiatry. 2004;12(6):339–350. - PubMed
-
- Washton AM. Group therapy with outpatients. In: Lowinson JH, Ruiz P, Millman RB, Langrod JG, editors. Substance Abuse: A Comprehensive Textbook. 4. Lippincott Williams & Wilkins; 2005. pp. 671–679.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
